MP: Key content Favipiravir found missing in Favimax tablets for treating COVID-19
'It was informed that Favipiravir, a key content, was not found in the seized Favimax tablets,' Agrawal said, adding the allegedly fake tablets were supplied by a firm registered with a fake address.;
Advertisement
Gwalior: Authorities seized a consignment of allegedly spurious Favimax tablets used in the COVID-19 treatment from a wholesaler here in Madhya Pradesh following an input given by the Odisha government, an official said on Tuesday.
Authorities also seized the stock of some other medicines on Monday night and sent their samples for testing, he said. A Madhya Pradesh Food and Drug Administration (FDA) official said 35,000 of the 40,000 Favimax (Favipiravir) tablets received from a firm in Odisha had already been sold by the wholesaler in Gwalior after receiving the stock in April this year.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.